KOMU19h
FDA approves first new schizophrenia drug in more than 30 years
The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.
Positive Outlook for Bristol-Myers Squibb with Promising Market Access and Societal Benefits of Cobenfy
Analyst David Risinger of Leerink Partners reiterated a Buy rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target ...
BioSpace3d
5 Novel FDA Approvals Notched in 2024
Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...
CNBC on MSN8d
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
AbbVie's $3.5 Billion Blow: Can Bold Bets Revive Its Profit Forecasts?
AbbVie's $3.5 Billion Blow: Can Bold Bets Revive Its Profit Forecasts?
Pick of the stats: Coventry v Bristol City
Coventry City are unbeaten across their past four home league games against Bristol City (W2 D2), since a 3-1 loss in October ...
Akron.com18h
Coventry trustees hear road department updates
Susan Haury Davis passed away on November 21, 2024 after a long illness. Susan is survived by her husband, Jim Davis; sister, Nancy Archey and nieces, Chrissie and Karen. Due to her long career as ...